Bottom line
What is POBAX's expense ratio?
POBAX's expense ratio is 1.16%, or about $116 a year on every $10,000 invested. That is more expensive than 71% of allocation / balanced funds we track (median 0.91%). This share class also charges a front-end sales load of up to 5.5%, taken from your investment when you buy. Its expense ratio includes a 0.25% 12b-1 marketing fee.
Updated Aug 3, 2026
POBAX fee table
| Net expense ratio | 1.16% |
|---|---|
| Gross expense ratio | 1.16% |
| Management fee | 0.45% |
| 12b-1 (distribution) fee | 0.25% |
| Acquired fund fees | 0.46% |
| Max front-end sales load | 5.5% |
| Max deferred sales charge | 0% |
Source: Fund prospectus fee table, filed Aug 3, 2026
What POBAX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| POBAX | $662 | $898 | $1,153 | $1,881 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 1.16% expense ratio costs roughly $63,400 in lost growth, versus about $50,800 for the median allocation / balanced fund (0.91%).